Sedative-hypnotic use disorders US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Sedative-hypnotic use disorders. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Sedative-hypnotic use disorders US Medical PG Question 1: A 32-year-old man is brought to the emergency department because he was found stumbling in the street heedless of oncoming traffic. On arrival, he is found to be sluggish and has slow and sometimes incoherent speech. He is also drowsy and falls asleep several times during questioning. Chart review shows that he has previously been admitted after getting a severe cut during a bar fight. Otherwise, he is known to be intermittently homeless and has poorly managed diabetes. Serum testing reveals the presence of a substance that increases the duration of opening for an important channel. Which of the following symptoms may be seen if the most likely substance in this patient is abruptly discontinued?
- A. Tremors
- B. Insomnia
- C. Delayed delirium
- D. Piloerection
- E. Seizures (Correct Answer)
Sedative-hypnotic use disorders Explanation: ***Seizures***
- This patient presents with symptoms of **central nervous system (CNS) depression** (sluggish, incoherent speech, drowsiness) and a history suggestive of **substance abuse** (homelessness, bar fight).
- The key clue is that the substance **increases the duration of opening** of the GABA-A receptor channel, which specifically describes **barbiturates** (benzodiazepines increase the **frequency** of opening, not duration).
- Abrupt discontinuation of barbiturates can lead to life-threatening **withdrawal seizures** due to CNS hyperexcitability when GABAergic inhibition is suddenly removed [1].
- This is the most critical and potentially fatal complication of barbiturate withdrawal.
*Tremors*
- While **tremors** can occur during withdrawal from CNS depressants, they are a less severe symptom compared to seizures.
- Tremors are common in withdrawal syndromes but do not represent the most life-threatening risk in acute barbiturate withdrawal.
*Insomnia*
- **Insomnia** is a common symptom of withdrawal from CNS depressants due to rebound CNS hyperactivity [1].
- However, compared to seizures, insomnia is not life-threatening and is a less critical feature of barbiturate withdrawal.
*Delayed delirium*
- **Delirium** can occur during severe withdrawal, particularly **delirium tremens** in alcohol withdrawal.
- While delirium may develop, the most immediate and severe risk for barbiturate withdrawal is seizures, which can occur within hours to days of cessation.
*Piloerection*
- **Piloerection** (goosebumps) is a classic symptom of **opioid withdrawal**, resulting from sympathetic nervous system activation.
- This symptom is **not** characteristic of withdrawal from barbiturates or other GABAergic substances, making it an incorrect choice.
Sedative-hypnotic use disorders US Medical PG Question 2: A 53-year-old woman is brought to the emergency department by her husband because of difficulty walking, slurred speech, and progressive drowsiness. The husband reports that his wife has appeared depressed over the past few days. She has a history of insomnia and social anxiety disorder. She appears lethargic. Her temperature is 36.2°C (97.1°F), pulse is 88/min, respirations are 12/min, and blood pressure is 110/80 mm Hg. Neurologic examination shows normal pupils. There is diffuse hypotonia and decreased deep tendon reflexes. Administration of a drug that acts as a competitive antagonist at which of the following receptors is most likely to reverse this patient's symptoms?
- A. D2 dopamine receptor
- B. Muscarinic acetylcholine receptor
- C. 5-hydroxytryptamine2 receptor
- D. GABAA receptor (Correct Answer)
- E. Ryanodine receptor
Sedative-hypnotic use disorders Explanation: ***GABAA receptor***
- The patient's symptoms of **sedation**, **slurred speech**, **ataxia** (difficulty walking), **diffuse hypotonia**, and **decreased deep tendon reflexes** are classic signs of **benzodiazepine overdose**.
- **Benzodiazepines** act as **positive allosteric modulators** at the GABA-A receptor, enhancing the effects of GABA and increasing chloride influx, leading to neuronal hyperpolarization and central nervous system depression. A **competitive antagonist** like **flumazenil** can reverse these effects.
*D2 dopamine receptor*
- Antagonism of **D2 dopamine receptors** is associated with **antipsychotic medications** and can lead to **extrapyramidal symptoms** or neuroleptic malignant syndrome, which do not match the patient's presentation.
- While dopamine receptors are involved in mood, their acute antagonism would not explain the rapid-onset, severe CNS depression described.
*Muscarinic acetylcholine receptor*
- **Muscarinic antagonists** (e.g., atropine, scopolamine) cause anticholinergic effects like **dry mouth**, **mydriasis**, **tachycardia**, and **delirium**, which are not observed in this patient.
- Reversal of these receptors would only be indicated in cases of anticholinergic toxicity, not the present signs of CNS depression.
*5-hydroxytryptamine2 receptor*
- **5-HT2 receptor antagonists** are used in some antipsychotics or for migraine prophylaxis, and their primary effects are not central nervous system depression of this nature.
- Overactivation or inhibition of these receptors does not typically manifest with the specific constellation of symptoms seen here (hypotonia, decreased reflexes, prominent sedation).
*Ryanodine receptor*
- **Ryanodine receptors** are primarily involved in **calcium release from the sarcoplasmic reticulum** in muscle cells, playing a role in muscle contraction.
- Drugs acting on these receptors (e.g., dantrolene for malignant hyperthermia) affect muscle tone and contractility, but not the broad CNS depression symptoms presented in this case.
Sedative-hypnotic use disorders US Medical PG Question 3: A 79-year-old man, hospitalized for overnight monitoring after elective surgery, is found on morning rounds to be confused and disoriented. He was recovering well in the post-anesthesia care unit before being moved up to the inpatient floor unit; however, he was found to be delirious and agitated overnight. Therefore, he was given a dose of a drug that affects the opening frequency of a neuronal ion channel. During morning rounds, he is found to have weakness, tremors, uncoordinated muscle movements, blurred vision, and disorientation. Which of the following could be used to reverse the drug that was administered to this patient?
- A. Flumazenil (Correct Answer)
- B. Activated charcoal
- C. Naloxone
- D. Ammonium chloride
- E. Sodium bicarbonate
Sedative-hypnotic use disorders Explanation: ***Flumazenil***
- The patient exhibits symptoms of **benzodiazepine overdose**, likely from medication given for agitation, which include confusion, disorientation, weakness, and uncoordinated movements.
- **Flumazenil** is a selective competitive antagonist of the **GABA-A receptor**, effectively reversing the effects of benzodiazepines.
*Activated charcoal*
- **Activated charcoal** is used for drug overdose by **adsorbing toxins** in the gastrointestinal tract, preventing systemic absorption.
- It is not an antidote for central nervous system depressant toxicities once the drug has already been absorbed and exerted its effects, and it is most effective when administered shortly after ingestion.
*Naloxone*
- **Naloxone** is an opioid receptor antagonist used to reverse the effects of **opioid overdose**, primarily respiratory depression.
- The patient's symptoms are inconsistent with opioid overdose, which would typically present with pinpoint pupils and respiratory depression rather than the described neurological and motor deficits.
*Ammonium chloride*
- **Ammonium chloride** is used to **acidify urine** to increase the excretion of basic drugs.
- It does not directly reverse the central nervous system effects of an overdose and is not a specific antidote for benzodiazepine toxicity.
*Sodium bicarbonate*
- **Sodium bicarbonate** is used to **alkalinize urine** to promote the excretion of acidic drugs, or to treat metabolic acidosis or certain drug toxicities like tricyclic antidepressants.
- It would not reverse the direct neurological effects of a benzodiazepine overdose.
Sedative-hypnotic use disorders US Medical PG Question 4: An 8-year-old boy is brought to the emergency department by his parents 30 minutes after losing consciousness. He was at a water park with his family when he fell to the ground and started to have jerking movements of the arms and legs. On arrival, he continues to have generalized, violent muscle contractions and is unresponsive to verbal and painful stimuli. The emergency department physician administers lorazepam. The expected beneficial effect of this drug is most likely caused by which of the following mechanisms?
- A. Increased affinity of GABAA receptors for GABAB agonists
- B. Noncompetitive NMDA receptor antagonism
- C. Increased duration of chloride channel opening
- D. Allosteric activation of GABAA receptors (Correct Answer)
- E. Inhibition of GABA transaminase
Sedative-hypnotic use disorders Explanation: ***Allosteric activation of GABAA receptors***
- **Lorazepam** is a **benzodiazepine** that acts as a positive allosteric modulator of the **GABAA receptor**.
- This binding enhances the effect of **GABA**, leading to increased frequency of **chloride channel opening** and neuronal hyperpolarization, which ultimately suppresses seizure activity.
*Increased affinity of GABAA receptors for GABAB agonists*
- This statement is incorrect because lorazepam acts on **GABAA receptors** and does not increase the affinity for **GABAB agonists**.
- **GABAB agonists** like baclofen act on a different receptor subtype and have a distinct mechanism of action.
*Noncompetitive NMDA receptor antagonism*
- This mechanism describes drugs like **ketamine** or **phencyclidine (PCP)**, which block the **NMDA receptor** to produce anesthetic or dissociative effects.
- Lorazepam's primary action is on the **GABAA receptor**, not the **NMDA receptor**.
*Increased duration of chloride channel opening*
- While benzodiazepines increase chloride influx, they primarily do so by increasing the **frequency** of **chloride channel opening**, not the duration.
- **Barbiturates**, such as phenobarbital, are known to increase the **duration** of chloride channel opening.
*Inhibition of GABA transaminase*
- **GABA transaminase** is an enzyme responsible for GABA metabolism. Its inhibition would lead to increased GABA levels in the synapse.
- **Valproic acid** is an example of an antiepileptic drug that inhibits **GABA transaminase**, but this is not the mechanism of action for lorazepam.
Sedative-hypnotic use disorders US Medical PG Question 5: A 21-year-old female is brought by her brother to the emergency department after having a generalized tonic-clonic seizure one hour ago. She is slightly confused and has no recollection of her seizure. Her brother relayed that the patient has a history of severe anxiety for which she takes medication. For the past several days, he noticed that his sister exhibited body tremors, appeared to be agitated with quick mood changes, and, at times, was delirious. He states his sister recently ran out of her medications while visiting from out of town. Which of the following would best treat the patient's condition?
- A. Varenicline
- B. Naloxone
- C. Methadone
- D. Diazepam (Correct Answer)
- E. Flumazenil
Sedative-hypnotic use disorders Explanation: ***Diazepam***
- The patient's presentation suggests **benzodiazepine withdrawal**, characterized by anxiety, tremors, agitation, mood swings, delirium, and seizures. **Diazepam**, a long-acting benzodiazepine, is the most appropriate treatment to reverse these withdrawal symptoms.
- Benzodiazepines work by enhancing the effect of **GABA** (gamma-aminobutyric acid), an inhibitory neurotransmitter, and withdrawal leads to a state of neuronal hyperexcitability.
*Varenicline*
- **Varenicline** is a medication used for **smoking cessation**.
- It acts as a partial agonist at nicotinic acetylcholine receptors and is not indicated for benzodiazepine withdrawal.
*Naloxone*
- **Naloxone** is an **opioid antagonist** used to reverse opioid overdose.
- It has no role in the management of benzodiazepine withdrawal.
*Methadone*
- **Methadone** is a long-acting opioid agonist primarily used for **opioid dependence treatment** and chronic pain management.
- It is not indicated for treating benzodiazepine withdrawal symptoms.
*Flumazenil*
- **Flumazenil** is a **benzodiazepine receptor antagonist** (competitive antagonist at the benzodiazepine binding site on the GABA-A receptor) used to reverse benzodiazepine overdose.
- Administering **flumazenil** in a patient with benzodiazepine dependence can precipitate or worsen withdrawal symptoms, including seizures, and is therefore contraindicated.
Sedative-hypnotic use disorders US Medical PG Question 6: A 34-year-old woman is brought to the emergency department by fire and rescue after an apparent suicide attempt. She reports ingesting several pills 6 hours prior to presentation but cannot recall what they were. No pills were found on the scene. She complains of severe malaise, ringing in her ears, and anxiety. Her past medical history is notable for bipolar disorder, generalized anxiety disorder, rheumatoid arthritis, obesity, and diabetes. She takes lithium, methotrexate, metformin, and glyburide. She has a reported history of benzodiazepine and prescription opioid abuse. Her temperature is 102.2°F (39°C), blood pressure is 135/85 mmHg, pulse is 110/min, and respirations are 26/min. On exam, she appears diaphoretic and pale. Results from an arterial blood gas are shown:
pH: 7.48
PaCO2: 32 mmHg
HCO3-: 23 mEq/L
This patient should be treated with which of the following?
- A. Ammonium chloride
- B. Atropine
- C. Sodium bicarbonate (Correct Answer)
- D. Flumazenil
- E. Physostigmine
Sedative-hypnotic use disorders Explanation: ***Sodium bicarbonate***
- This patient presents with symptoms highly suggestive of **salicylate (aspirin) overdose**: tinnitus, tachypnea, hyperthermia, altered mental status, and **respiratory alkalosis** on ABG.
- **Sodium bicarbonate** is the treatment of choice to **alkalinize the urine** (target pH 7.5-8.0), which increases renal excretion of salicylates by trapping the ionized form in the urine.
- Salicylate toxicity initially causes **respiratory alkalosis** (direct stimulation of the respiratory center), and can progress to **metabolic acidosis** in severe cases due to uncoupling of oxidative phosphorylation.
*Ammonium chloride*
- **Ammonium chloride** is an acidifying agent and would be **contraindicated** in salicylate toxicity.
- Acidifying the urine would increase reabsorption of salicylate and worsen toxicity.
- It has limited use in toxicology for enhancing excretion of basic drugs, but not applicable here.
*Atropine*
- **Atropine** is an anticholinergic agent used to treat bradycardia or organophosphate/cholinergic poisoning.
- It is not indicated for salicylate toxicity and would not address the patient's acid-base disturbance or enhance drug elimination.
*Flumazenil*
- **Flumazenil** is a benzodiazepine receptor antagonist used to reverse **benzodiazepine overdose**.
- While the patient has a history of benzodiazepine abuse, her presentation (tinnitus, hyperthermia, tachypnea, respiratory alkalosis) is classic for **salicylate toxicity**, not benzodiazepine overdose.
- Flumazenil also carries risk of precipitating seizures in patients with chronic benzodiazepine use.
*Physostigmine*
- **Physostigmine** is a cholinesterase inhibitor used to treat **anticholinergic toxicity** (e.g., from antihistamines, TCAs).
- The patient's symptoms are inconsistent with anticholinergic poisoning (which would present with hyperthermia, dry skin, mydriasis, urinary retention, altered mental status).
- This patient has diaphoresis and tachypnea, more consistent with salicylate toxicity.
Sedative-hypnotic use disorders US Medical PG Question 7: A 16-year-old boy with history of seizure disorder is rushed to the Emergency Department with multiple generalized tonic-clonic seizures that have spanned more than 30 minutes in duration. He has not regained consciousness between these episodes. In addition to taking measures to ensure that he maintains adequate respiration, which of the following is appropriate for initial pharmacological therapy?
- A. Carbamazepine
- B. Gabapentin
- C. Lorazepam (Correct Answer)
- D. Valproic acid
- E. Phenytoin
Sedative-hypnotic use disorders Explanation: ***Lorazepam***
- This patient is experiencing **status epilepticus**, defined by continuous seizures lasting over 5 minutes or recurrent seizures without regaining consciousness. **Intravenous benzodiazepines**, like lorazepam, are the first-line treatment due to their rapid onset of action on GABA receptors.
- **Lorazepam** is preferred over other benzodiazepines in this setting due to its relatively **longer duration of action** and availability as an intravenous formulation, effectively terminating the acute seizure.
*Carbamazepine*
- **Carbamazepine** is an oral **anti-epileptic drug** used for long-term control of focal seizures, but it is not suitable for acute management of status epilepticus due to its **slow onset of action** and lack of intravenous formulation for rapid effect.
- It works by blocking **voltage-gated sodium channels**, which is not the primary mechanism for immediate seizure termination in an emergency.
*Gabapentin*
- **Gabapentin** is an anti-epileptic medication primarily used for focal seizures and neuropathic pain, and is **not effective** in treating acute generalized tonic-clonic seizures or status epilepticus.
- Its mechanism of action involves modulation of **calcium channels** and GABA, but it has a **slow onset** and limited efficacy in acute seizure termination.
*Valproic acid*
- **Valproic acid** can be used in the long-term management of various seizure types, including generalized tonic-clonic seizures, and has an intravenous formulation, but it is **not the first-line choice for immediate termination** of status epilepticus.
- Benzodiazepines are typically administered first, and if they fail, valproic acid can be considered as a **second-line agent** along with other antiepileptics.
*Phenytoin*
- **Phenytoin** is a classic anti-epileptic drug that can be used intravenously as a **second-line agent** for status epilepticus if benzodiazepines are unsuccessful.
- It has a slower onset of action compared to benzodiazepines and carries risks such as **cardiac arrhythmias** and **hypotension** with rapid infusion, making it less ideal for initial therapy.
Sedative-hypnotic use disorders US Medical PG Question 8: A 58-year-old right-handed man is brought to the emergency department after he was found unconscious in his living room by his wife. She reports that he has never had a similar episode before. The patient has hypertension and consumes multiple alcoholic drinks per day. On arrival, he is confused and oriented only to person. He cannot recall what happened. He has difficulty speaking and his words are slurred. He reports a diffuse headache and muscle pain and appears fatigued. His temperature is 37°C (98.6°F), pulse is 85/min, respirations are 14/min, and blood pressure is 135/70 mm Hg. Examination shows a 2-cm bruise on his right shoulder. Strength is 5/5 throughout, except for 1/5 in the left arm. The remainder of the physical examination shows no abnormalities. An ECG shows left ventricular hypertrophy. A CT scan of the head without contrast shows no abnormalities. Which of the following is the most likely underlying cause of this patient's symptoms?
- A. Syncope
- B. Seizure (Correct Answer)
- C. Transient ischemic attack
- D. Stroke
- E. Migraine
Sedative-hypnotic use disorders Explanation: ***Seizure***
- The patient's **postictal confusion**, **slurred speech**, **diffuse headache**, and **muscle pain** following a transient loss of consciousness are highly suggestive of a seizure. The unilateral weakness (**Todd's paralysis**) is also a classic postictal phenomenon.
- The **bruise on his shoulder** could indicate a fall during the event, and his alcohol consumption and hypertension are risk factors for seizures.
*Syncope*
- Syncope is characterized by a **brief loss of consciousness due to global cerebral hypoperfusion**, usually followed by rapid and complete recovery of consciousness and neurological function.
- The patient's **prolonged confusion**, **slurred speech**, and **unilateral weakness** after the event are inconsistent with typical syncope.
*Transient ischemic attack*
- A TIA involves **transient neurological dysfunction caused by focal brain or retinal ischemia**, without acute infarction. Symptoms typically resolve within 24 hours.
- While the **slurred speech** and **unilateral weakness** (left arm 1/5 strength) might mimic TIA symptoms, the preceding **loss of consciousness** and subsequent **prolonged postictal state** are not characteristic of a TIA.
*Stroke*
- A stroke involves **brain tissue damage due to ischemia or hemorrhage**, leading to persistent neurological deficits.
- Although he presents with **unilateral weakness** and **slurred speech**, the **head CT without contrast** showed **no abnormalities**, ruling out acute ischemic stroke within the typical detection window for initial CT (within a few hours) and hemorrhagic stroke, and the preceding **loss of consciousness** and **postictal symptoms** point away from a primary stroke.
*Migraine*
- Migraine is a **primary headache disorder** often accompanied by neurological symptoms (aura) but typically does not involve a complete **loss of consciousness**.
- While he has a **diffuse headache**, the **loss of consciousness**, **unilateral weakness**, and **postictal confusion** are inconsistent with migraine.
Sedative-hypnotic use disorders US Medical PG Question 9: A 34-year-old man presents to the behavioral health clinic for an evaluation after seeing animal-shaped clouds in the form of dogs, cats, and monkeys. The patient says that these symptoms have been present for more than 2 weeks. Past medical history is significant for simple partial seizures for which he takes valproate, but he has not had his medication adjusted in several years. His vital signs include: blood pressure of 124/76 mm Hg, heart rate of 98/min, respiratory rate of 12/min, and temperature of 37.1°C (98.8°F). On physical examination, the patient is alert and oriented to person, time, and place. Affect is not constricted or flat. Speech is of rapid rate and high volume. Pupils are equal and reactive bilaterally. The results of a urine drug screen are as follows:
Alcohol positive
Amphetamine negative
Benzodiazepine negative
Cocaine positive
GHB negative
Ketamine negative
LSD negative
Marijuana negative
Opioids negative
PCP negative
Which of the following is the most likely diagnosis in this patient?
- A. Delusion
- B. Alcohol withdrawal
- C. Visual hallucination
- D. Cocaine intoxication
- E. Illusion (Correct Answer)
Sedative-hypnotic use disorders Explanation: ***Illusion***
- The patient is seeing **animal shapes in the clouds**, which is a misinterpretation of a real external stimulus. This is the definition of an **illusion**.
- Unlike hallucinations, illusions involve a distorted perception of an existing object, rather than perceiving something that is not present.
*Delusion*
- A **delusion** is a **fixed, false belief** that is not amenable to change in light of conflicting evidence, and it is not what is being described here.
- The patient is experiencing a perceptual distortion, not a false belief system.
*Alcohol withdrawal*
- While the patient tests positive for alcohol, the symptoms described are **perceptual distortions** (misinterpretation of clouds), not typical signs of alcohol withdrawal which include tremors, seizures, and delirium tremens.
- The timeline of "more than 2 weeks" also makes acute alcohol withdrawal less likely, as withdrawal symptoms typically peak within days.
*Visual hallucination*
- A **hallucination** is a perception in the absence of an external stimulus; the patient would be seeing animals when no clouds (or other visual stimuli) are present.
- The patient is seeing animal shapes *in the clouds*, indicating an existing external stimulus that is being misinterpreted.
*Cocaine intoxication*
- While cocaine intoxication can cause psychiatric symptoms like paranoia and hallucinations, the specific description of **seeing animal shapes in clouds** (misinterpretation of a real stimulus) points more directly to an illusion rather than a primary effect of cocaine use.
- The patient's presentation does not include other common symptoms of acute cocaine intoxication like severe agitation, dilated pupils, or hyperthermia beyond a rapid heart rate.
Sedative-hypnotic use disorders US Medical PG Question 10: A 30-year-old man with schizophrenia stabilized on clozapine presents to establish care at a new clinic. Records show stable psychiatric symptoms for 2 years. Routine urine drug screen is positive for cocaine. He admits to using cocaine 2-3 times monthly at parties but denies it affects his functioning. He has maintained employment, housing, and medication adherence. He refuses substance use treatment, stating 'it's recreational and under control.' His last clozapine level was therapeutic. Evaluate the management approach balancing psychiatric stability, substance use, and patient autonomy.
- A. Mandate substance use treatment as condition for continuing clozapine
- B. Switch to long-acting injectable antipsychotic with lower risk profile
- C. Discontinue clozapine due to medication non-compliance and substance use risk
- D. Continue clozapine with harm reduction counseling, more frequent monitoring, and motivational interviewing for substance use (Correct Answer)
- E. Involuntarily hospitalize for dual diagnosis treatment program
Sedative-hypnotic use disorders Explanation: ***Continue clozapine with harm reduction counseling, more frequent monitoring, and motivational interviewing for substance use***
- The patient has been **psychiatrically stable** on clozapine for two years and maintains high functioning; discontinuing a life-saving medication for **treatment-resistant schizophrenia** due to intermittent substance use risks severe decompensation.
- A **harm reduction** approach utilizing **motivational interviewing** addresses the cocaine use without damaging the therapeutic alliance, while **increased monitoring** manages potential risks like a **lowered seizure threshold** or cardiac strain.
*Mandate substance use treatment as condition for continuing clozapine*
- Coercive strategies often lead to **patient dropout** and treatment non-adherence, which could result in a relapse of psychosis.
- Medical ethics prioritize **patient autonomy**; treatment mandates are generally reserved for situations where the patient lacks capacity or poses an immediate danger.
*Switch to long-acting injectable antipsychotic with lower risk profile*
- **Clozapine** is uniquely effective for patients who have failed other treatments; switching a stable patient to a **long-acting injectable (LAI)** may lead to a loss of symptom control.
- The patient's **medication adherence** is already documented as excellent, so the primary benefit of an LAI—improving compliance—is not a current clinical priority.
*Discontinue clozapine due to medication non-compliance and substance use risk*
- The patient is actually **compliant** with his clozapine regimen, as evidenced by his **therapeutic drug levels** and stable psychiatric status.
- Discontinuation represents a high-risk clinical decision that ignores the **biopsychosocial stability** the patient has achieved despite his recreational drug use.
*Involuntarily hospitalize for dual diagnosis treatment program*
- **Involuntary hospitalization** requires the patient to be a **danger to self or others** or be gravely disabled, none of which apply to this stable, employed individual.
- Forced treatment for substance use is not legally supported in this context and would be a significant overreach that violates **civil liberties**.
More Sedative-hypnotic use disorders US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
